Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Subscribe to Newsletter Newsletter   RSS Feeds RSS Feeds

Video Releases    |    Pricing & Distribution Plans    |    Today's News    |    News By Category    |    News By Date    |    Business Directory
All Press Releases for April 08, 2010 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version    Bookmark del.icio.us    Diggs



Eidogen-Sertanty Releases iKinasePro - an iPad App in the Cloud
Eidogen-Sertanty released iKinasePro, a new mobile application enabling chemical substructure and similarity searching on the iPad while leveraging a cloud-based server infrastructure 
x-small text small text medium text large text


    OCEANSIDE, CA, April 08, 2010 /24-7PressRelease/ -- Eidogen-Sertanty, Inc., a San Diego-based computational drug discovery solutions provider, announced the release of iKinasePro, a new mobile application enabling chemical substructure and similarity searching on the iPad while leveraging a cloud-based server infrastructure.

iKinasePro provides access into a version of Eidogen-Sertanty's popular Kinase Knowledgebase (KKB) hosted in Amazon's cloud computing environment. Using native iPad functionality, a user can survey the large and growing KKB by target-name, by Kinome-tree taps, and by structure-based searches. Users can register for e-mail alerts to notify them when additional information becomes available on molecules of interest.

iKinasePro introduces new "search-by-tap" functionality that allows a user to explore the world of kinases by tapping through a vast array of kinase-relevant ring structures, or by tapping on subfamilies within the Kinome tree. Users can also issue custom structure searches through finger-drawn substructures.

"We are very excited to bring together two cutting-edge technologies for this application," said Dr. Steven Muskal, CEO of Eidogen-Sertanty. "The iPad is truly a revolutionary device that is expected to change the shape of mobile computing. Coupling these handheld devices with a highly scalable and cost-effective cloud-based server-side compute infrastructure is a match made in heaven."

To see the application in the App store, please see iKinasePro for the iPad

For addition information, please see kinasedata.com

For more information, please contact:

Steve Muskal
760-651-2885
pr@eidogen-sertanty.com

Eidogen-Sertanty is a privately held company that is dedicated to helping scientists discover new medicines with innovative software technology and knowledgebases. To find out more about Eidogen-Sertanty please visit www.eidogen-sertanty.com.


---
Press release service and press release distribution provided by http://www.24-7pressrelease.com


# # #

Press Release Keywords:
Read more Press Releases from Steven Muskal:

Press Release Service & Press Release Distribution News Supplied By 24-7PressRelease.com
Social Media:
Share or bookmark this story using Facebook, Twitter, Digg, and more.

Bookmark and Share
Press Release Contact Information:
Steven Muskal
Eidogen-Sertanty

CEO
3460 Marron Rd Ste 103-475
Oceanside, CA
USA 92056
Voice: 760-651-2885
Fax: 760-775-822-1721
E-Mail: Email us Here
Website: Visit Our Website
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release. We are unable to assist you with any information regarding this release. 24-7 Press Release disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.